Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19

Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19

Aim. To evaluate the potential of a fixed-dose combination of lisinopril+amlodipine+rosuvastatin (Equamer®) in achieving additional vascular protection in patients with hypertension and high pulse wave velocity (PWV) after severe and very severe coronavirus disease 2019 (COVID-19), complicated by bi...

Full description

Bibliographic Details
Main Authors: S. V. Nedogoda, A. A. Ledyaeva, E. V. Chumachek, V. V. Tsoma, A. S. Salasyuk, V. O. Lutova, E. A. Popova, D. S. Vlasov, O. I. Bychkova, V. A. Labaznikova, K. S. Evdokimov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2022-01-01
Series:Российский кардиологический журнал
Subjects:
hypertension
covid-19
pulse wave velocity
central blood pressure
augmentation index
inflammation
combined antihypertensive therapy
lisinopril
amlodipine
rosuvastatin
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4766

Internet

https://russjcardiol.elpub.ru/jour/article/view/4766

Similar Items